Today: 22 January 2026
Subscribe
Browse Category

Pharmaceuticals News 9 January 2026 - 10 January 2026

Johnson & Johnson stock dips on Trump drug-price deal — what to watch before Monday

Johnson & Johnson stock dips on Trump drug-price deal — what to watch before Monday

New York, January 10, 2026, 10:58 ET — Market closed Johnson & Johnson shares fell 0.7% on Friday, closing at $204.39. The company said it reached an agreement with the U.S. government to lower drug prices in exchange for exemptions from tariffs. (Reuters) The timing matters: drugmakers are heading into another round of pricing battles abroad, particularly in Europe, after…
10 January 2026
···
Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

NEW YORK, January 10, 2026, 10:08 EST — Market closed Eli Lilly & Co shares fell 2% on Friday to $1,063.56, underperforming a stronger broader market and extending a two-day slide. The stock is now 6.21% below its 52-week high of $1,133.95 set on Thursday, while trading volume ran below its recent average. The pullback lands as investors re-price big…
10 January 2026
····
Liquidia stock jumps 13% after $148M Yutrepia sales update; what investors watch next

Liquidia stock jumps 13% after $148M Yutrepia sales update; what investors watch next

New York, Jan 10, 2026, 09:08 ET — Market closed Key points: Liquidia Corporation shares climbed 12.9% on Friday to $35.86, extending a sharp run after the drugmaker laid out preliminary 2025 sales for its inhaled pulmonary hypertension drug, Yutrepia. The update matters because Yutrepia is now the engine of the story, not a promise. It is also a test…
10 January 2026
····
Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears

Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears

NEW YORK, Jan 10, 2026, 06:23 EST — Market closed Hims & Hers Health, Inc. (HIMS) shares fell 6.4% on Friday to $31.69, with about 25 million shares changing hands. The stock is down roughly 11% over the past two sessions as investors weighed Amazon Pharmacy’s move into Novo Nordisk’s Wegovy weight-loss pill business. (StockAnalysis) That matters now because Hims…
10 January 2026
····
GSK stock: $50m Noetik deal and Jemperli royalty lawsuit sharpen focus on Feb 4 results

GSK stock: $50m Noetik deal and Jemperli royalty lawsuit sharpen focus on Feb 4 results

New York, Jan 10, 2026, 03:42 EST — Market closed AnaptysBio said it filed a motion asking a U.S. court to dismiss part of a claim by GSK plc’s oncology unit, escalating a dispute over royalties tied to sales of cancer drug Jemperli, a PD-1 inhibitor — a kind of immunotherapy that helps the immune system attack tumours. Tesaro sued…
10 January 2026
···
Johnson & Johnson stock: TrumpRx drug discounts win tariff waiver as earnings loom

Johnson & Johnson stock: TrumpRx drug discounts win tariff waiver as earnings loom

New York, January 9, 2026, 21:25 EST — Market closed Johnson & Johnson said it has struck a deal with President Donald Trump’s administration to cut U.S. drug prices, securing exemptions from U.S. tariffs, or import taxes, on its pharmaceutical products. Johnson & Johnson stock closed down 0.7% at $204.39 on Friday. (Reuters) The agreement lands as the White House…
10 January 2026
····
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

New York, Jan 9, 2026, 20:01 (EST) — Market closed. Merck & Co (MRK.N) shares slipped on Friday following reports that the pharma giant is in talks to acquire cancer-focused biotech Revolution Medicines (RVMD.O) for as much as $32 billion. Merck ended the day down 0.4% at $110.53, after swinging between $110.26 and $112.46. (Reuters) The possible bid comes as…
10 January 2026
···
Amazon stock edges up after-hours as Amazon Pharmacy adds Novo’s Wegovy pill

Amazon stock edges up after-hours as Amazon Pharmacy adds Novo’s Wegovy pill

Amazon.com (AMZN.O) shares rose 0.4% in after-hours trading on Friday after Amazon Pharmacy said it has begun offering Novo Nordisk’s (NOVOb.CO) Wegovy weight-loss pill via insurance plans as well as a cash-pay option. Customers who qualify and have commercial insurance could pay $25 for a one-month supply, while cash-pay begins at $149; the U.S. FDA approved the pill in December,…
9 January 2026
····
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

New York, Jan 9, 2026, 15:52 EST — Regular session Shares of Hims & Hers Health, Inc (HIMS.N) fell 5.3% to $32.06 on Friday, after Amazon Pharmacy said it now offers Novo Nordisk’s Wegovy weight-loss pill, raising the pressure on telehealth sellers chasing obesity drug demand. The stock hit an intraday high of $34.35 before sliding to a session low…
9 January 2026
···
CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

New York, Jan 9, 2026, 15:11 EST — Regular session CRISPR Therapeutics AG shares slid on Friday, bucking a firmer broader market, after a regulatory filing flagged a chief financial officer’s share sale under a pre-arranged trading plan. (Reuters) The company’s CFO, Raju Prasad, exercised stock options for 29,700 common shares and sold 29,700 shares the same day at prices…
9 January 2026
···
Johnson & Johnson stock slips on Trump drug-price pact as tariff relief comes into view

Johnson & Johnson stock slips on Trump drug-price pact as tariff relief comes into view

New York, Jan 9, 2026, 14:40 (EST) — Regular session Johnson & Johnson shares slipped about 0.5% to $204.76 on Friday after the company said it struck an agreement with President Donald Trump’s administration to lower drug prices for Americans in return for exemptions from U.S. tariffs. Johnson & Johnson did not say which medicines are included or how large…
9 January 2026
··
AbbVie stock slips on $1.3B charge, deal-rumor denial — what’s next for ABBV

AbbVie stock slips on $1.3B charge, deal-rumor denial — what’s next for ABBV

NEW YORK, Jan 9, 2026, 12:28 PM EST — Regular session AbbVie Inc (ABBV) shares fell about 0.8% in midday New York trade on Friday after the drugmaker trimmed its 2025 profit outlook and brushed off a report tying it to a takeover of cancer biotech Revolution Medicines. The stock was down $1.78 at $222.35. AbbVie said in an emailed…
9 January 2026
····
1 … 8 9 10 11 12 … 45

Stock Market Today

  • Vanguard S&P 500 ETF Gains 17% in 12 Months, Faces High Valuation Concerns
    January 22, 2026, 11:24 AM EST. The Vanguard S&P 500 ETF (VOO) delivered a strong 17% total return over the past year, reflecting solid U.S. economic growth and the power of 500 leading companies. Over the past decade, VOO's annualized return reached about 15.9%, helped by low interest rates, tech sector dominance, and a surge in passive investing. However, market experts warn of stretched valuations, with the cyclically adjusted price-to-earnings (CAPE) ratio hitting 40.8, a level only seen during the 1999-2000 dot-com boom. This metric signals potential pressure on future returns, suggesting the ETF may face headwinds if valuations normalize.
Go toTop